N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy

ClinicalTrials.gov ID: NCT01265563

Public ClinicalTrials.gov record NCT01265563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Correction of Glutathione Deficiency for Treatment of Diabetic Nephropathy

Study identification

NCT ID: NCT01265563
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: VA Office of Research and Development; Federal
Enrollment: 108 participants

Conditions and interventions

Conditions

Interventions

N-acetylcysteine placebo and silibin placebo Drug
N-acetylcysteine active and silibin placebo Drug
N-acetylcysteine placebo and silibin active Drug
N-acetylcysteine active and silibin active Drug
N-acetylcysteine active + high-dose silibin active Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 76 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2010
Primary completion: Jan 31, 2015
Completion: Nov 30, 2016
Last update posted: Oct 18, 2018

2011 – 2016

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
South Texas Health Care System, San Antonio, TX	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01265563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 18, 2018 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01265563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →